news

In the Media

2021-02-18 // New $300 Million Venture Fund Spotlights Role Of Women In Venture Capital And Public Health

Go to Article

2021-02-18 // Investment firm raises $300M to fund medical research for overlooked diseases

Go to Article

2020-12-14 // Codagenix, Serum Institute to begin UK trials of nasal COVID-19 vaccine in January

Go to Article

2020-10-15 // Evofem Biosciences Secures $25 Million Strategic Investment from Adjuvant Capital

Go to Article

2020-09-22 // India’s Serum Institute starts manufacturing Codagenix’s potential COVID-19 vaccine

Go to Article

2020-09-11 // Merck Covid-19 Vaccine Begins Human Testing

Go to Article

Adjuvant seeks out the most innovative life sciences companies in the world.

See our Portfolio